Safety and efficacy of the M2A patency capsule for diagnosis of critical intestinal patency: Results of a prospective clinical trial

被引：33

作者：

Banerjee, Rupa ^{[1
]}

Bhargav, Prem ^{[1
]}

Reddy, Praveen ^{[1
]}

Gupta, Rajesh ^{[1
]}

Lakhtakia, Sandeep ^{[1
]}

Tandan, Manu ^{[1
]}

Rao, Venkat G. ^{[1
]}

Reddy, Nageshwar D. ^{[1
]}

机构：

[1] Asian Inst Gastroenterol, Hyderabad, Andhra Pradesh, India

来源：

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2007年 / 22卷 / 12期

关键词：

capsule endoscopy; intestinal stricture; M2A patency capsule; patency;

D O I：

10.1111/j.1440-1746.2007.05039.x

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Background and Aim: The presence of a critical intestinal stricture is a contraindication for conventional capsule endoscopy for the risk of impaction. Prior assessment of intestinal patency can substantially minimize this risk. The aim of the present study was to assess the safety and efficacy of the M2A patency capsule (PC) for verification of intestinal strictures. Methods: The M2A PC consists of a biodegradable body surrounding a small radiofrequency identification (RFID) tag. This capsule was administered to patients with known or suspected intestinal strictures. Patency was verified if the capsule was excreted intact. The capsule disintegrated into small fragments and only the RFID tag was excreted if retained at the stricture beyond a stipulated time. The patency scanner was used to detect the RFID tag externally. The M2A video capsule (VC) was administered to patients who excreted the intact capsule. Results: Twenty-six patients with known or suspected intestinal strictures were administered the M2A PC. This included 16 (61%) patients with tuberculosis, eight (31%) with Crohn's disease, and one each of postoperative and malignant strictures. Eight capsules were excreted intact within 72 h and two at 109 and 110 h. Fifteen capsules disintegrated in the G(I) tract and one capsule was removed during surgery. No PC-related complications were noted. Six of the eight patients who tested positive for patency were tested with the regular M2A VC with normal excretion. Conclusion: The M2A PC is a reliable indicator of functional patency in suspected or even known cases of intestinal stricture. It could be used prior to conventional capsule endoscopy to predict and minimize the risk of impaction.

引用

页码：2060 / 2063

页数：4

共 18 条

[1]

[Anonymous], DIG ENDOSC

[2]

BARKIN JS, 2002, AM J GASTROENTEROL, V15, P363

[3]

BOIVIN HL, 2003, ENDOSCOPY, V35, pA184

[4]

BOIVIN M, 2004, C P 3 INT C CAPS END

[5] Does passage of a patency capsule indicate small-bowel patency? A prospective clinical trial? [J].

Boivin, ML ;

Lochs, H ;

Voderholzer, WA .

ENDOSCOPY, 2005, 37 (09) :808-815

[6]

BOLVIN M, 2004, C P 3 INT C CAPS END

[7]

COHEN SA, 2005, C P 4 INT C CAPS END

[8] A prospective trial comparing small bowel radiographs and video capsule endoscopy for suspected small bowel disease [J].

Costamagna, G ;

Shah, SK ;

Riccioni, ME ;

Foschia, F ;

Mutignani, M ;

Perri, V ;

Vecchioli, A ;

Brizi, MG ;

Picciocchi, A ;

Marano, P .

GASTROENTEROLOGY, 2002, 123 (04) :999-1005

[9]

Costamagna G, 2004, GASTROINTEST ENDOSC, V59, pAB145

[10] Clinical evaluation of the use of the M2A patency capsule system before a capsule endoscopy procedure, in patients with known or suspected intestinal stenosis [J].

Delvaux, M ;

Ben Soussan, E ;

Laurent, V ;

Lerebours, E ;

Gay, G .

ENDOSCOPY, 2005, 37 (09) :801-807

← 1 2 →